Lighthouse Pharma's strategy combines translational insights with considerable clinical experience to understand and treat dementia.
Lighthouse Pharma has raised $15.2M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Lighthouse Pharma's investors include National Institute on Aging, Double Point Ventures.
Lighthouse Pharma is headquartered in Novato, United States.
Lighthouse Pharma's strategy combines translational insights with considerable clinical experience to understand and treat dementia.
Lighthouse Pharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lighthouse Pharma — Funding & Investors." VCBacked, April 23, 2026, https://www.vcbacked.co/company/lighthouse-pharma. Accessed August 14, 2026.
VCBacked. (2026). Lighthouse Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/lighthouse-pharma
{{cite web |title=Lighthouse Pharma — Funding & Investors |url=https://www.vcbacked.co/company/lighthouse-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated